Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

SERETIDE vs FLIXOTIDE in Mild Persistent Asthma (GINAII)

NCT00455923 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT00455923
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00455923 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
SERETIDE vs FLIXOTIDE in Mild Persistent Asthma (GINAII)
Lead sponsor
GlaxoSmithKline
Phase
Phase 4
Overall status
Completed
Start date
May 3, 2005
Completion date
July 31, 2007
Enrollment
100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

asthma